Algemeen Ziekenhuis Damiaan Oostende

Ostend 18 trials 7 recruiting

18 Registered trials

7 Currently recruiting

Organisation

Algemeen Ziekenhuis Damiaan Oostende

Location

Ostend, Belgium

Identifier

ORG-100042525

Address

Gouwelozestraat 100, 8400, Belgium

Departments

Cardiology
Endocrinology
Endocrinology and diabetes
Gastroenterology
Gastroenterology and hepatology department
Medical Oncology
n/a
Neurology
Oncology
Urology

Clinical trials at this site (18)

Search interface

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin ( ENLIGHTEN-6 ) Recruiting

2025-523659-73-00 Obesity 5 2026-05-11
A phase 2b, randomized, double-blind study of redasemtide (S-005151) in adult participants with acute ischemic stroke Recruiting

2022-501890-38-00 acute ischemic stroke 4 2024-02-16
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney D… Recruiting

2025-523123-22-00 Chronic Kidney Disease 5 2026-05-07
A Phase 2, open label, randomized study of neoadjuvant dostarlimab plus CAPEOX versus CAPEOX in participants with previously untreated T4N0 … Recruiting

2024-513441-36-00 MMRp/ MSS colon cancer 4 2024-11-27
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting

2023-503267-42-00 Patients with a histological diagnosis of mismatch- rep 5 2022-06-10
Low INR to Minimize bleeding with mechanical valves Trial (LIMIT) Recruiting

2023-508532-56-00 Treatment with a Vitamin K Antagonist due to having a m 5 2021-10-19
ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer Recruiting

2023-506857-40-00 Prostate Cancer 5 2019-01-08
Controlled Interruption of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Infections Ended

2024-511016-25-00 Chronic hepatitis B infection 4 2025-01-15
Subcutaneous infliximab after a previous intravenous dose optimization (AMARETTO trial) Ended

2023-508166-15-00 Ulcerative colitis (UC), Inflammatory bowel disease typ 6 2024-04-29
A study to evaluate the safety, tolerability and the effects of Ixodes ricinus-Contact Phase Inhibitor (Ir-CPI) in adult patients with spont… Ended

2022-500491-53-00 Spontaneous intracerebral haemorrhage 4 2023-07-27
A Study of Tirzepatide (LY3298176) on the Reduction of Morbidity and Mortality in Adults With Obesity (SURMOUNT- MMO) Ended

2022-501744-15-00 Obesity, Overweight 5 2023-01-23
Management of moderate POstoperative recurrence in Crohn's disease: a randoMizEd contROLled trial of therapeutic escalation, the POMEROL tri… Ended

2023-508242-18-00 Crohn's disease 6 2021-12-21
A phase III, international, multiCenter, randomized, paraLlel-group, Endoscopist-blinded non-inferiority study of the efficAcy, safety and p… Ended

2025-521451-23-00 Subjects scheduled for elective colonoscopy performed a 5 2025-09-03
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) Ended

2022-500101-41-00 Type 2 Diabetes 6 2023-06-07
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CV… Ended

2023-507846-96-00 Type 2 Diabetes Mellitus 5 2020-06-19
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities (SURMOUNT-5) Ended

2022-501106-35-00 Obesity Overweight 5
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan… Ended

2023-506487-13-00 Hormone receptor-positive, her2-negative advanced/metas 5